drugset / Trial / NCT02396433
Combination of Carboplatin, Eribulin Mesylate, and E7449 in BRCA-Related Cancers
NaSingle-groupOpen-labelTreatment
Summary
Non-randomized, open-label, multi-center, phase I/II, dose-escalation study of the combination of carboplatin, eribulin, and E7449.
Timeline
- Start
- 2015-04
- Primary completion
- 2015-04
- Completion
- 2015-04
Outcome
Outcome not reported
Stopped (Business): “lack of funding.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 2X-121 | Small molecule | — | — |
| Subject | Carboplatin | Small molecule | — | — |
| Subject | Eribulin | Small molecule | — | — |